MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$2,222,435K
(111.90%↑ Y/Y)
Inventory
$1,273,221K
(-0.13%↓ Y/Y)
Accounts receivable, net
$903,914K
(22.29%↑ Y/Y)
Other current assets
$205,500K
(13.20%↑ Y/Y)
Total current assets
$4,605,070K
(32.79%↑ Y/Y)
Deferred tax assets
$1,500,598K
(2.74%↑ Y/Y)
Property, plant and
equipment, net
$958,071K
(-7.22%↓ Y/Y)
Restricted cash
equivalents
$850,000K
Other assets
$276,416K
(17.30%↑ Y/Y)
Intangible assets, net
$204,662K
(-17.26%↓ Y/Y)
Goodwill
$196,199K
(0.00%↑ Y/Y)
Total assets
$8,591,016K
(20.20%↑ Y/Y)
Total liabilities and
stockholders equity
$8,591,016K
(20.20%↑ Y/Y)
Total stockholders
equity
$6,212,107K
(7.23%↑ Y/Y)
Total liabilities
$2,378,909K
(75.75%↑ Y/Y)
Company common stock
held by the...
$10,450K
(-6.50%↓ Y/Y)
Accumulated other
comprehensive loss
-$4,237K
(-122.12%↓ Y/Y)
Additional paid-in capital
$5,966,868K
(2.98%↑ Y/Y)
Retained earnings
$259,733K
(2983.04%↑ Y/Y)
Long-term debt, net
$1,430,282K
Total current
liabilities
$793,152K
(26.26%↑ Y/Y)
Other long-term
liabilities
$155,475K
(19.89%↑ Y/Y)
Common stock, 0.001 par
value 500,000,000...
$193K
(0.52%↑ Y/Y)
Accounts payable and
accrued liabilities
$793,152K
(26.26%↑ Y/Y)
Back
Back
Balance Sheet
biomarin-logo-svg
source: myfinsight.com
BIOMARIN PHARMACEUTICAL INC (BMRN)
biomarin-logo-svg
BIOMARIN PHARMACEUTICAL INC (BMRN)